Heron Therapeutics预期2025年销售额为1.53亿至1.63亿美元,对比预期为1.60633亿美元

财报速递
27 Feb
2025年财务指引,Heron Therapeutics预计全年净收入为1.53亿至1.63亿美元。调整后的EBITDA预计将在0到800万美元之间。

以上内容来自Benzinga Earnings专栏,原文如下:

Financial Guidance for 2025 

Item

2025 Full-Year Guidance for Net Revenue and Adjusted EBITDA

(in millions)

Net Revenue

$153.0

to

$163.0
Adjusted EBITDA$0.0to$8.0

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10